NBIX - Neurocrine Biosciences Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - NBIX (914475)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
78 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-02-07
NBIXRoberts EiryChief Medical OfficerS - Sale$103.31-1,6237,452-18%-$167,675
DM
2020-02-07
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$104.52-29,98423,200-56%-$3,133,912
2020-02-07
NBIXLippoldt DarinGCS - Sale$103.32-1,52224,124-6%-$157,247
2020-02-07
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$103.31-1,218111,682-1%-$125,833
2020-02-07
NBIXGorman Kevin CharlesCEOS - Sale$103.36-3,248432,357-1%-$335,696
2020-02-07
NBIXGano KyleChief Business Development OffS - Sale$103.33-1,62391,975-2%-$167,710
2020-02-07
NBIXCooke JulieCHROS - Sale$103.26-9134,643-16%-$94,276
2020-02-07
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$103.33-1,623146,641-1%-$167,702
2020-02-07
NBIXBenevich EricChief Commercial OfficerS - Sale$103.32-2,03020,087-9%-$209,747
2020-02-07
NBIXAbernethy MattCFOS - Sale$103.35-2,0305,701-26%-$209,807
DM
2020-02-05
NBIXGano KyleChief Business Development OffS - Sale+OE$102.70-4,69090,514-5%-$481,675
DM
2020-02-05
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$102.58-2,421110,587-2%-$248,351
DM
2020-02-05
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$102.38-3,43822,287-13%-$351,991
DM
2020-02-05
NBIXLippoldt DarinGCS - Sale+OE$102.36-2,94822,755-11%-$301,763
DM
2020-02-05
NBIXGorman Kevin CharlesCEOS - Sale+OE$102.41-9,792429,436-2%-$1,002,793
D
2020-02-05
NBIXCooke JulieCHROS - Sale+OE$103.17-6053,821-14%-$62,417
DM
2020-02-05
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$102.43-3,441145,180-2%-$352,449
DM
2020-02-05
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$102.38-3,34918,262-15%-$342,872
2020-01-08
NBIXRoberts EiryChief Medical OfficerS - Sale$111.11-2,6325,991-31%-$292,445
2019-12-02
NBIXAbernethy MattCFOS - Sale$116.33-1,6453,876-30%-$191,360
D
2019-11-18
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$115.98-5,000108,408-4%-$579,900
2019-11-08
NBIXLyons Gary ADirS - Sale$110.00-5,000225,697-2%-$550,000
D
2019-11-08
NBIXLippoldt DarinGCS - Sale+OE$110.01-10,00020,103-33%-$1,100,057
2019-11-01
NBIXLyons Gary ADirS - Sale$100.22-5,000230,697-2%-$501,104
D
2019-11-01
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$100.34-10,188108,408-9%-$1,022,298
D
2019-10-14
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$90.85-9,95619,613-34%-$904,487
2019-10-02
NBIXCooke JulieCHROS - Sale$88.56-9873,276-23%-$87,409
D
2019-09-03
NBIXLippoldt DarinGCS - Sale+OE$100.00-6,73620,103-25%-$673,600
DM
2019-08-23
NBIXLippoldt DarinGCS - Sale+OE$100.05-3,26419,961-14%-$326,555
DM
2019-08-06
NBIXGorman Kevin CharlesCEOS - Sale+OE$95.31-80,000417,597-16%-$7,624,975
2019-07-30
NBIXLyons Gary ADirS - Sale$92.07-10,000235,697-4%-$920,686
D
2019-07-30
NBIXLippoldt DarinGCS - Sale+OE$92.13-15,83119,961-44%-$1,458,569
D
2019-07-30
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$92.92-60,000108,408-36%-$5,575,438
D
2019-07-30
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$92.77-44,356141,976-24%-$4,114,858
D
2019-07-15
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.50-30,680141,976-18%-$2,684,506
2019-07-15
NBIXBenevich EricChief Commercial OfficerS - Sale$87.44-5,83514,910-28%-$510,201
DM
2019-07-10
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.63-7,220141,976-5%-$632,717
D
2019-06-18
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$87.82-2,100141,976-1%-$184,417
D
2019-06-13
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$82.62-17,268141,976-11%-$1,426,628
D
2019-06-03
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.51-3,435141,976-2%-$293,719
D
2019-05-31
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$85.02-19,297141,976-12%-$1,640,581
D
2019-05-24
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-17,486141,976-11%-$1,399,434
D
2019-05-22
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.03-1,300141,976-1%-$104,037
D
2019-05-16
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$80.13-66,667141,976-32%-$5,341,893
2019-05-13
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$75.44-1,657118,408-1%-$125,007
D
2019-05-13
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$75.51-34,547141,976-20%-$2,608,813
D
2019-02-06
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$83.58-92019,238-5%-$76,894
D
2019-02-06
NBIXLippoldt DarinGCS - Sale+OE$83.52-79119,646-4%-$66,063
D
2019-02-06
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$84.03-531120,0650%-$44,622
D
2019-02-06
NBIXGorman Kevin CharlesCEOS - Sale+OE$84.22-4,096417,597-1%-$344,986
D
2019-02-06
NBIXGano KyleChief Business Development OffS - Sale+OE$83.56-76285,833-1%-$63,673
D
2019-02-06
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$83.54-920141,639-1%-$76,859
D
2019-02-06
NBIXBenevich EricChief Commercial OfficerS - Sale+OE$83.57-92020,745-4%-$76,883
2019-02-05
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale$88.14-1,27217,508-7%-$112,119
2019-02-05
NBIXLippoldt DarinGCS - Sale$88.09-1,22518,162-6%-$107,911
M
2019-02-04
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$88.14-2,445119,071-2%-$215,505
M
2019-02-04
NBIXGorman Kevin CharlesCEOS - Sale$88.16-7,614413,943-2%-$671,216
M
2019-02-04
NBIXGano KyleChief Business Development OffS - Sale$88.12-3,80984,695-4%-$335,668
M
2019-02-04
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale$88.12-2,725139,909-2%-$240,125
2019-02-05
NBIXBenevich EricChief Commercial OfficerS - Sale$88.01-1,35719,015-7%-$119,427
2019-01-08
NBIXRoberts EiryChief Medical OfficerS - Sale$84.09-1,8573,143-37%-$156,159
2018-12-03
NBIXAbernethy MattCFOS - Sale$90.00-1,1781,947-38%-$106,020
2018-11-26
NBIXPops Richard FDirS - Sale$91.37-4,12429,512-12%-$376,790
2018-11-12
NBIXPops Richard FDirS - Sale$103.30-4,12333,636-11%-$425,893
D
2018-11-08
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.00-36,295135,997-21%-$3,992,450
DM
2018-11-06
NBIXBozigian Haig P.CHIEF DEVELOPMENT OFFICERS - Sale+OE$110.13-38,819135,997-22%-$4,275,300
DM
2018-11-06
NBIXLloyd-Smith MalcolmChief Regulatory OfficerS - Sale+OE$110.01-9,00015,318-37%-$990,096
2018-11-02
NBIXLyons Gary ADirS - Sale$114.41-15,000245,697-6%-$1,716,213
2018-10-29
NBIXPops Richard FDirS - Sale$107.13-5,50037,759-13%-$589,237
D
2018-08-01
NBIXGano KyleChief Business Development OffS - Sale+OE$115.00-28,26678,742-26%-$3,250,590
D
2018-08-01
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$110.00-23,02282,942-22%-$2,532,420
D
2018-06-20
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$105.00-23,00082,942-22%-$2,415,000
2018-06-13
NBIXLyons Gary ADirS - Sale$99.24-15,000260,697-5%-$1,488,549
DM
2018-06-13
NBIXGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale+OE$99.48-86,96382,942-51%-$8,650,738
2018-06-11
NBIXSherwin Stephen ADirS - Sale$98.44-10,00047,548-17%-$984,420
2018-06-01
NBIXBenevich EricChief Commercial OfficerS - Sale$97.34-12,35016,690-43%-$1,202,164
2018-05-07
NBIXNevinny Corinne HDirS - Sale$83.12-5,00043,283-10%-$415,625
D
2018-05-01
NBIXGorman Kevin CharlesCEOS - Sale+OE$80.75-126,832347,033-27%-$10,241,735
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top